EFFICACY OF ADJUVANT CHEMOTHERAPY IN HIGH-RISK NODE-NEGATIVE BREAST-CANCER - AN INTERGROUP STUDY

被引：337
|
作者：
MANSOUR, EG
GRAY, R
SHATILA, AH
OSBORNE, CK
TORMEY, DC
GILCHRIST, KW
COOPER, MR
FALKSON, G
机构：
[1] HARVARD UNIV,SCH PUBL HLTH,DANA FARBER CANC INST,BOSTON,MA 02115
[2] UNIV TEXAS,HLTH SCI CTR,SAN ANTONIO,TX 78284
[3] UNIV WISCONSIN,CTR CLIN CANC,MADISON,WI 53706
[4] WAKE FOREST UNIV,BOWMAN GRAY SCH MED,WINSTON SALEM,NC 27103
[5] UNIV PRETORIA,PRETORIA,SOUTH AFRICA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 1989年 / 320卷 / 08期
关键词：
D O I：
10.1056/NEJM198902233200803
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：485 / 490
页数：6
相关论文
共 50 条
  • [31] PROGNOSIS IN NODE-NEGATIVE BREAST-CANCER
    VANDEVELDE, CJH
    GALLAGER, HS
    GIACCO, GG
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1986, 8 (03) : 189 - 196
  • [32] Identification of patients with high-risk lymph node-negative colorectal cancer and potential benefit from adjuvant chemotherapy
    Oñate-Ocaña, LF
    Montesdeoca, R
    López-Graniel, CM
    Aiello-Crocifoglio, V
    Mondragón-Sánchez, R
    Cortina-Borja, M
    Herrera-Goepfert, R
    Oros-Ovalle, C
    Gallardo-Rincón, D
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 34 (06) : 323 - 328
  • [33] TREATMENT OF NODE-NEGATIVE BREAST-CANCER
    LONG, D
    [J]. AMERICAN FAMILY PHYSICIAN, 1991, 44 (02) : 448 - 448
  • [34] CONCOMITANT ADJUVANT CHEMOTHERAPY AND RADIOTHERAPY FOR HIGH-RISK BREAST-CANCER PATIENTS
    HANSEN, R
    ERICKSON, B
    KOMAKI, R
    JANJAN, N
    COX, J
    WILSON, JF
    ANDERSON, T
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1991, 17 (03) : 171 - 177
  • [35] Adjuvant Docetaxel for Node-Negative Breast Cancer
    Venniyoor, Ajit
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (10): : 976 - 977
  • [36] Adjuvant chemotherapy in small node-negative triple-negative breast cancer (TNBC).
    Steenbruggen, Tessa Gerjanne
    Van Ramshorst, Mette S.
    van Werkhoven, Erik
    Dezentje, Vincent O.
    Siesling, Sabine
    Linn, Sabine C.
    Sonke, Gabe S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [37] Quality of Life Following Receipt of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node-Positive and High-Risk Lymph Node-Negative Breast Cancer
    Rosenberg, Shoshana M.
    O'Neill, Anne
    Sepucha, Karen
    Miller, Kathy D.
    Dang, Chau T.
    Northfelt, Donald W.
    Sledge, George W.
    Schneider, Bryan P.
    Partridge, Ann H.
    [J]. JAMA NETWORK OPEN, 2022, 5 (02)
  • [38] RAPID GROWTH-RATE - A METHOD OF IDENTIFYING NODE-NEGATIVE BREAST-CANCER PATIENTS WITH A HIGH-RISK OF RECURRENCE
    CHARLSON, ME
    FEINSTEIN, AR
    [J]. JOURNAL OF CHRONIC DISEASES, 1983, 36 (12): : 847 - 853
  • [39] ADJUVANT THERAPY OF NODE-NEGATIVE BREAST-CANCER - ANOTHER POINT OF VIEW - RESPONSE
    GLICK, JH
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (13) : 1076 - 1076
  • [40] Side effects of adjuvant chemotherapy: Perceptions of node-negative breast cancer patients
    Beisecker, AE
    Cook, MR
    Ashworth, J
    Hayes, J
    Brecheisen, M
    Helmig, L
    Hyland, S
    Selenke, D
    [J]. PSYCHO-ONCOLOGY, 1997, 6 (02) : 85 - 93
12345